MENU
+Compare
TRUMY
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$13.01
Change
-$3.33 (-20.38%)
Capitalization
19.46B

TRUMY Terumo Corp. Forecast, Technical & Fundamental Analysis

Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue... Show more

TRUMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TRUMY with price predictions
Feb 03, 2026

TRUMY's RSI Indicator descending into oversold zone

The RSI Oscillator for TRUMY moved into overbought territory on February 03, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where TRUMY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRUMY advanced for three days, in of 292 cases, the price rose further within the following month. The odds of a continued upward trend are .

TRUMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TRUMY as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TRUMY turned negative on January 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRUMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TRUMY entered a downward trend on February 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.075) is normal, around the industry mean (11.448). P/E Ratio (22.836) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (2.173) is also within normal values, averaging (2.437). Dividend Yield (0.014) settles around the average of (0.017) among similar stocks. P/S Ratio (2.809) is also within normal values, averaging (111.001).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRUMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRUMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TRUMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TRUMY is expected to report earnings to fall 6.04% to 14 cents per share on February 13

Terumo Corp. TRUMY Stock Earnings Reports
Q4'25
Est.
$0.14
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.01
The last earnings report on November 12 showed earnings per share of 15 cents, missing the estimate of 16 cents. With 264.71K shares outstanding, the current market capitalization sits at 19.46B.
A.I.Advisor
published Dividends

TRUMY paid dividends on July 12, 2024

Terumo Corp. TRUMY Stock Dividends
А dividend of $0.14 per share was paid with a record date of July 12, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
2-44-1 Hatagaya
Phone
+81 333748111
Employees
26482
Web
https://www.terumo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VKQ9.790.01
+0.10%
Invesco Municipal Trust
PAAA51.37N/A
N/A
PGIM AAA CLO ETF
FAB94.35N/A
N/A
First Trust Multi Cap Val AlphaDEX® ETF
QLVE31.22-0.03
-0.08%
FlexShares EMs Quality Lw Vol ETF
MPLY29.93-0.52
-1.69%
Monopoly ETF

TRUMY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-1.66%
HOCPY - TRUMY
51%
Loosely correlated
+3.34%
SSMXY - TRUMY
45%
Loosely correlated
-0.43%
SMTI - TRUMY
43%
Loosely correlated
-6.80%
OLYMY - TRUMY
40%
Loosely correlated
-1.24%
AZTA - TRUMY
39%
Loosely correlated
-1.65%
More

Groups containing TRUMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-1.66%
Pharmaceuticals: Other
industry (107 stocks)
27%
Poorly correlated
-0.12%
Pharmaceuticals
industry (380 stocks)
21%
Poorly correlated
-0.30%